Pro-inflammatory cytokines for evaluation of inflammatory status in endometriosis

Central European Journal of Immunology

Volumn 40, Issue 1, 2015, Pages 96-102

  Malutan, Andrei M ^a   Drugan, Tudor ^a   Costin, Nicolae ^a   Ciortea, Razvan ^a   Bucuri, Carmen ^a   Rada, Maria P ^a   Mihu, Dan ^a  

^a IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Cytokine; Endometriosis; Inflammation; Interleukin

Indexed keywords

INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD LEVEL; CASE CONTROL STUDY; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SEVERITY; ENDOMETRIOSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MENSTRUATION;

EID: 84928491944     PISSN: 14263912     EISSN: 16444124     Source Type: Journal    
DOI: 10.5114/ceji.2015.50840     Document Type: Article

References (40)

1. Giudice LC, Kao LC (2004): Endometriosis. Lancet 364: 1789-1799.
2. Mounsey A, Wilgus A, Slawson DC (2006): Diagnosis and management of endometriosis. Am Fam Physician 74: 594-600.
3. Othman Eel-D, Hornung D, Salem HT, et al. (2008): Serum cytokines as biomarkers for nonsurgical prediction of endometriosis. Eur J Obstet Gynecol Reprod Biol 137: 240-246.
4. Yagmur E, Bastu E, Karamustafaoglu-Balci B, et al. (2013): Non-invasive diagnosis of endometriosis based on a combined analysis of four plasma biomarkers. Centr Eur J Immunol 38: 154-158.
5. Bulun SE (2009): Endometriosis. N Engl J Med 360: 268-279.
6. Kubatova A, Erdem A, Erdem M, et al. (2013): Serum cytokine and growth factor levels in patients with endometriosis. Centr Eur J Immunol 38: 500-504.
7. Carmona F, Chapron C, Martínez-Zamora MA, et al. (2012): Ovarian endometrioma but not deep infiltrating endometriosis is associated with increased serum levels of interleukin-8 and interleukin-6. J Reprod Immunol 95: 80-86.
8. Moini A, Malekzadeh F, Amirchaghmaghi E, et al. (2013): Risk factors associated with endometriosis among infertile Iranian women. Arch Med Sci 9: 506-514.
9. Agic A, Xu H, Finas D, et al. (2006): Is endometriosis associated with systemic subclinical inflammation? Gynecol Obstet Invest 62: 139-147.
10. Kilic SH, Evsen S, Tasdemir N, et al. (2007): Follicular fluid vascular endothelial growth factor and tumour necrosis factor a concentration in patients with endometriosis undergoing ICSI. Reprod Biomed Online 15: 316-320.
11. Zulfikaroglu E, Kilic S, Islimye M, et al. (2011): Efficacy of anti-tumor necrosis factor therapy on endometriosis in an experimental rat model. Arch Gynecol Obstet 283: 799-804.
12. Bedaiwy MA, Falcone T, Sharma RK, et al. (2002): Prediction of endometriosis with serum and peritoneal fluid markers: a prospective controlled trial. Hum Reprod 17: 426-431.
13. Revised American Society for Reproductive Medicine classification of endometriosis: 1996 (1997): Fertil Steril 67: 817-821.
14. Wu MY, Ho HN (2003): The role of cytokines in endometriosis. Am J Reprod Immunol 49: 285-296.
15. OuYang Z, Hirota Y, Osuga Y, et al. (2008): Interleukin-4 stimulates proliferation of endometriotic stromal cells. Am J Pathol 173: 463-469.
16. Berkkanoglu M, Arici A (2003): Immunology and endometriosis. Am J Reprod Immunol 50: 48-59.
17. Dmowski WP, Braun DP (2004): Immunology of endometriosis. Best Pract Res Clin Obstet Gynaecol 18: 245-263.
18. Bedaiwy MA, Falcone T (2004): Laboratory testing for endometriosis. Clin Chim Acta 340: 41-56.
19. Ohata Y, Harada T, Miyakoda H, et al. (2008): Serum interleukin-8 levels are elevated in patients with ovarian endometrioma. Fertil Steril 90: 994-999.
20. Martínez S, Garrido N, Coperias JL, et al. (2007): Serum interleukin-6 levels are elevated in women with minimal-mild endometriosis. Hum Reprod 22: 836-842.
21. Mier-Cabrera J, Jiménez-Zamudio L, García-Latorre E, et al. (2011): Quantitative and qualitative peritoneal immune profiles, T-cell apoptosis and oxidative stress-associated characteristics in women with minimal and mild endometriosis. BJOG 118: 6-16.
22. Khan KN, Masuzaki H, Fujishita A, et al. (2004): Higher activity by opaque endometriotic lesions than nonopaque lesions. Acta Obstet Gynecol Scand 83: 375-382.
23. Velasco I, Acién P, Campos A, et al. (2010): Interleukin-6 and other soluble factors in peritoneal fluid and endometriomas and their relation to pain and aromatase expression. J Reprod Immunol 84: 199-205.
24. Somigliana E, Vigano P, Tirelli AS, et al. (2004): Use of the concomitant serum dosage of CA 125, CA 19-9 and interleu-kin-6 to detect the presence of endometriosis. Results from a series of reproductive age women undergoing laparoscopic surgery for benign gynaecological conditions. Hum Reprod 19: 1871-1876.
25. Milewski Ł, Barcz E, Dziunycz P, et al. (2008): Association of leptin with inflammatory cytokines and lymphocyte subpopulations in peritoneal fluid of patients with endometriosis. J Reprod Immunol 79: 111-117.
26. Milewski Ł, Dziunycz P, Barcz E, et al. (2001): Increased levels of human neutrophil peptides 1, 2, and 3 in peritoneal fluid of patients with endometriosis: association with neutrophils, T cells and IL-8. J Reprod Immunol 91: 64-70.
27. Lu D, Song H, Shi G (2013): Anti-TNF-α treatment for pelvic pain associated with endometriosis. Cochrane Database Syst Rev 3:CD008088.
28. Cho SH, Oh YJ, Nam A, et al. (2007): Evaluation of serum and urinary angiogenic factors in patients with endometriosis. Am J Reprod Immunol 58: 497-504.
29. Lee GH, Choi YM, Kim SH, et al. (2008): Association of tumor necrosis factor-a gene polymorphisms with advanced stage endometriosis. Human Reproduction 23: 977-981.
30. Teramoto M, Kitawaki J, Koshiba H, et al. (2004): Genetic contribution of tumor necrosis factor (TNF)-alpha gene promoter (-1031,-863 and -857) and TNF receptor 2 gene polymorphisms in endometriosis susceptibility. Am J Reprod Immunol 51: 352-357.
31. Rogus J, Beck JD, Offenbacher S, et al. (2008): IL1B gene promoter haplotype pairs predict clinical levels of interleukin-1beta and C-reactive protein. Hum Genet 123: 387-398.
32. Singh H, Sachan R, Goel H, Mittal B (2008): Genetic variants of interleukin-1RN and interleukin-1b genes and risk of cervical cancer. BJOG 115: 633-638.
33. Wunder DM, Mueller MD, Birkhauser MH, Bersinger NA (2006): Increased ENA-78 in the follicular fluid of patients with endometriosis. Acta Obstet Gynecol Scand 85: 336-342.
34. Gupta S, Goldberg JM, Aziz N, et al. (2008): Pathogenic mechanisms in endometriosis-associated infertility. Fertil Steril 90: 247-257.
35. Lambert S, Santulli P, Chouzenoux S, et al. (2014): Endometriosis: Increasing concentrations of serum interleukin-1βand interleukin-1sRII is associated with the deep form of this pathology. J Gynecol Obstet Biol Reprod (Paris) 43: 735-743.
36. Kalu E, Sumar N, Giannopoulos T, et al. (2007): Cytokine profiles in serum and peritoneal fluid from infertile women with and without endometriosis. J Obstet Gynaecol Res 33: 490-495.
37. Wickiewicz D, Chrobak A, Gmyrek GB, et al. (2013): Diagnostic accuracy of interleukin-6 levels in peritoneal fluid for detection of endometriosis. Arch Gynecol Obstet 288: 805-814.
38. Drosdzol-Cop A, Skrzypulec-Plinta V (2012): Selected cytokines and glycodelin A levels in serum and peritoneal fluid in girls with endometriosis. J Obstet Gynaecol Res 38: 1245-1253.
39. Clayton DG, Walker NM, Smyth DJ, et al. (2005): Population structure, differential bias and genomic control in a large-scale, case-control association study. Nat Genet 37: 1243-1246.
40. Elshal MF, McCoy JP (2006): Multiplex bead array assays: performance evaluation and comparison of sensitivity to ELISA. Methods 38: 317-323.